We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
16.14%
Holding
579
New
177
Increased
129
Reduced
112
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$255M |
| 2 |
lululemon athletica
LULU
|
+$155M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$125M |
| 4 |
EPAM Systems
EPAM
|
+$124M |
| 5 |
Cigna
CI
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$244M |
| 2 |
Meta Platforms (Facebook)
META
|
+$239M |
| 3 |
Cisco
CSCO
|
+$133M |
| 4 |
Fortive
FTV
|
+$112M |
| 5 |
Nike
NKE
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.55% |
| 2 | Healthcare | 15.5% |
| 3 | Consumer Discretionary | 12.21% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFTX
326
Definium Therapeutics
DFTX
$5.99B
| $3.31M | 0.03% |
1,042,639
-57,361
| -5% | -$191K |
|
|
327
Fortive
FTV
$18.6B
| $3.29M | 0.03% |
64,091
-2,232,973
| -97% | -$112M |
|
|
ETWO
328
DELISTED
E2open Parent Holdings
ETWO
| $3.2M | 0.03% |
550,000
| – | – |
|
329
Bread Financial
BFH
$4.38B
| $3.18M | 0.03% |
104,891
-412,031
| -80% | -$15.4M |
|
|
DFTX
330
CALL
Definium Therapeutics
DFTX
$5.99B
| $3.17M | 0.03% |
+1,000,000
| New | +$3.32M |
|
331
CALL
GCM Grosvenor
GCMG
$834M
| $3.12M | 0.03% |
+400,000
| New | +$3.32M |
|
332
Solid Biosciences
SLDB
$918M
| $3.06M | 0.03% |
646,604
+106,457
| +20% | +$640K |
|
333
Tilray
TLRY
$602M
| $2.91M | 0.03% |
115,206
-10,000
| -8% | -$285K |
|
334
Latham Group
SWIM
$860M
| $2.75M | 0.02% |
962,350
-42,450
| -4% | -$149K |
|
335
OrthoPediatrics
KIDS
$608M
| $2.75M | 0.02% |
62,006
-51,527
| -45% | -$2.28M |
|
|
AVDX
336
DELISTED
AvidXchange
AVDX
| $2.73M | 0.02% |
350,000
+185,000
| +112% | +$1.78M |
|
|
ITCI
337
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.71M | 0.02% |
+50,000
| New | +$2.42M |
|
|
NSTG
338
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.69M | 0.02% |
271,515
-200,000
| -42% | -$1.98M |
|
339
Intuit
INTU
$91.5B
| $2.51M | 0.02% |
5,631
-5,630
| -50% | -$2.31M |
|
|
GTM
340
ZoomInfo Technologies
GTM
$1.23B
| $2.47M | 0.02% |
100,000
-75,000
| -43% | -$1.92M |
|
|
NKLA
341
DELISTED
Nikola Corporation Common Stock
NKLA
| $2.46M | 0.02% |
+67,733
| New | +$4.44M |
|
|
OTLY
342
Oatly Group
OTLY
$419M
| $2.42M | 0.02% |
+50,000
| New | +$2.34M |
|
343
CALL
Roivant Sciences
ROIV
$25.8B
| $2.41M | 0.02% |
+325,992
| New | +$2.68M |
|
|
ETNB
344
CALL
DELISTED
89bio
ETNB
| $2.28M | 0.02% |
+150,000
| New | +$1.96M |
|
|
EVBG
345
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.25M | 0.02% |
+65,000
| New | +$2.08M |
|
|
LSI
346
DELISTED
Life Storage, Inc.
LSI
| $2.25M | 0.02% |
17,144
-424,370
| -96% | -$49.1M |
|
|
NMRD
347
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $2.22M | 0.02% |
+2,483,271
| New | +$3.21M |
|
|
ORGN
348
CALL
DELISTED
Origin Materials
ORGN
| $2.22M | 0.02% |
+17,305
| New | +$2.56M |
|
|
SPRB
349
Spruce Biosciences
SPRB
$127M
| $2.21M | 0.02% |
+13,333
| New | +$2.48M |
|
|
CERE
350
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.14M | 0.02% |
87,782
| – | – |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2023 Portfolio in Review
As of Q1 2023, Alyeska Investment Group held 579 positions worth $11.4B, up 18% from $9.66B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group deployed $1.23B of net new capital in Q1 2023, opening 177 new positions and adding to 129 existing holdings. Its largest new stake was lululemon athletica: 495,506 shares worth $180M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Salesforce, an estimated $244M trimmed.
- Alyeska Investment Group's largest Q1 2023 buy was lululemon athletica: 495,506 shares worth $180M.
- Alyeska Investment Group added most to Adobe in Q1 2023, an estimated $255M increase.
- Alyeska Investment Group's biggest Q1 2023 reduction was Salesforce, cutting an estimated $244M.
- Alyeska Investment Group fully exited Domino's in Q1 2023, selling an estimated $95.7M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $11.4B portfolio in Q1 2023.
- Alyeska Investment Group opened 177 new positions and closed 139 in Q1 2023.
- Alyeska Investment Group's portfolio value rose 18% quarter-over-quarter to $11.4B.
Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.